Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HBD5
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 175 | 177 | PF00675 | 0.462 |
CLV_PCSK_KEX2_1 | 175 | 177 | PF00082 | 0.529 |
CLV_PCSK_SKI1_1 | 165 | 169 | PF00082 | 0.503 |
CLV_PCSK_SKI1_1 | 185 | 189 | PF00082 | 0.440 |
CLV_PCSK_SKI1_1 | 235 | 239 | PF00082 | 0.456 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.522 |
DOC_CYCLIN_RxL_1 | 180 | 192 | PF00134 | 0.374 |
DOC_MAPK_DCC_7 | 250 | 258 | PF00069 | 0.363 |
DOC_MAPK_gen_1 | 203 | 212 | PF00069 | 0.310 |
DOC_MAPK_MEF2A_6 | 250 | 258 | PF00069 | 0.363 |
DOC_PP2B_LxvP_1 | 105 | 108 | PF13499 | 0.406 |
DOC_PP2B_LxvP_1 | 196 | 199 | PF13499 | 0.469 |
DOC_PP4_FxxP_1 | 204 | 207 | PF00568 | 0.435 |
DOC_USP7_MATH_1 | 110 | 114 | PF00917 | 0.479 |
DOC_USP7_MATH_1 | 199 | 203 | PF00917 | 0.521 |
DOC_USP7_MATH_1 | 61 | 65 | PF00917 | 0.504 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.483 |
DOC_WW_Pin1_4 | 217 | 222 | PF00397 | 0.512 |
DOC_WW_Pin1_4 | 36 | 41 | PF00397 | 0.394 |
LIG_BIR_III_4 | 144 | 148 | PF00653 | 0.279 |
LIG_eIF4E_1 | 132 | 138 | PF01652 | 0.429 |
LIG_EVH1_2 | 5 | 9 | PF00568 | 0.345 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.341 |
LIG_FHA_1 | 189 | 195 | PF00498 | 0.516 |
LIG_FHA_1 | 39 | 45 | PF00498 | 0.406 |
LIG_FHA_2 | 239 | 245 | PF00498 | 0.534 |
LIG_LIR_Apic_2 | 202 | 207 | PF02991 | 0.440 |
LIG_LIR_Gen_1 | 109 | 118 | PF02991 | 0.366 |
LIG_LIR_Gen_1 | 21 | 30 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 109 | 114 | PF02991 | 0.375 |
LIG_LIR_Nem_3 | 21 | 25 | PF02991 | 0.327 |
LIG_LIR_Nem_3 | 229 | 234 | PF02991 | 0.466 |
LIG_PCNA_PIPBox_1 | 148 | 157 | PF02747 | 0.289 |
LIG_PTAP_UEV_1 | 39 | 44 | PF05743 | 0.288 |
LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.384 |
LIG_SH2_STAT5 | 15 | 18 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 154 | 157 | PF00017 | 0.469 |
LIG_SH2_STAT5 | 190 | 193 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 211 | 214 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.477 |
LIG_SH3_1 | 37 | 43 | PF00018 | 0.519 |
LIG_SH3_3 | 156 | 162 | PF00018 | 0.388 |
LIG_SH3_3 | 37 | 43 | PF00018 | 0.391 |
LIG_SUMO_SIM_anti_2 | 247 | 255 | PF11976 | 0.304 |
LIG_SUMO_SIM_par_1 | 191 | 197 | PF11976 | 0.276 |
LIG_TRAF2_1 | 220 | 223 | PF00917 | 0.486 |
MOD_CDK_SPxxK_3 | 1 | 8 | PF00069 | 0.328 |
MOD_CK1_1 | 112 | 118 | PF00069 | 0.321 |
MOD_CK1_1 | 140 | 146 | PF00069 | 0.437 |
MOD_CK1_1 | 18 | 24 | PF00069 | 0.395 |
MOD_CK1_1 | 202 | 208 | PF00069 | 0.410 |
MOD_CK1_1 | 245 | 251 | PF00069 | 0.493 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.420 |
MOD_CK2_1 | 217 | 223 | PF00069 | 0.559 |
MOD_CK2_1 | 238 | 244 | PF00069 | 0.536 |
MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.288 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.437 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.444 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.381 |
MOD_GSK3_1 | 222 | 229 | PF00069 | 0.332 |
MOD_GSK3_1 | 238 | 245 | PF00069 | 0.488 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.381 |
MOD_N-GLC_1 | 26 | 31 | PF02516 | 0.565 |
MOD_N-GLC_1 | 54 | 59 | PF02516 | 0.361 |
MOD_NEK2_1 | 137 | 142 | PF00069 | 0.288 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.474 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.353 |
MOD_NEK2_1 | 246 | 251 | PF00069 | 0.435 |
MOD_NEK2_1 | 257 | 262 | PF00069 | 0.437 |
MOD_NEK2_1 | 26 | 31 | PF00069 | 0.468 |
MOD_NEK2_1 | 98 | 103 | PF00069 | 0.358 |
MOD_PIKK_1 | 238 | 244 | PF00454 | 0.531 |
MOD_PKA_2 | 181 | 187 | PF00069 | 0.375 |
MOD_Plk_1 | 222 | 228 | PF00069 | 0.364 |
MOD_Plk_1 | 26 | 32 | PF00069 | 0.528 |
MOD_Plk_4 | 112 | 118 | PF00069 | 0.181 |
MOD_Plk_4 | 128 | 134 | PF00069 | 0.371 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.493 |
MOD_Plk_4 | 205 | 211 | PF00069 | 0.361 |
MOD_Plk_4 | 249 | 255 | PF00069 | 0.418 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.337 |
MOD_Plk_4 | 94 | 100 | PF00069 | 0.409 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.471 |
MOD_ProDKin_1 | 217 | 223 | PF00069 | 0.507 |
MOD_ProDKin_1 | 36 | 42 | PF00069 | 0.388 |
TRG_DiLeu_BaEn_1 | 164 | 169 | PF01217 | 0.456 |
TRG_DiLeu_BaEn_4 | 222 | 228 | PF01217 | 0.309 |
TRG_ER_diArg_1 | 174 | 176 | PF00400 | 0.463 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I7A3 | Leptomonas seymouri | 61% | 88% |
A0A0S4KLY1 | Bodo saltans | 29% | 79% |
A0A1X0PB14 | Trypanosomatidae | 45% | 87% |
A0A3Q8INV4 | Leishmania donovani | 82% | 100% |
A0A422NVB8 | Trypanosoma rangeli | 42% | 85% |
A4IAI3 | Leishmania infantum | 82% | 100% |
C9ZLQ5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 86% |
E9B5K7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 100% |
Q4Q2C9 | Leishmania major | 83% | 100% |
V5BLS2 | Trypanosoma cruzi | 39% | 86% |